What Numbers Will a Buyer or Private Equity Group Ask for Before Valuing Your Practice, and Can You Produce Them Today?

Buyers and private equity groups will ask for normalized EBITDA plus the operational numbers behind it: new patient trend by source, patient retention, provider concentration, payer mix, and per-location performance. Be able to produce each of these quickly and from one source. Buyers treat slow or conflicting answers as risk and lower their offers.

Revenue and profit set the starting point for valuation. What moves the multiple up or down is whether a buyer believes your earnings will continue after you sign. Each spreadsheet request during diligence either supports or weakens that belief.

TruVue is a healthcare practice operations intelligence platform (not an EMR) that consolidates operational data for independent practices and multi-location groups into one consistent view.

What financial numbers will a buyer ask for first?

Buyers start with earnings. According to PKF O'Connor Davies, clean organizational documents, accurate and timely financials, a clear calculation of normalized EBITDA and a credible quality of earnings analysis "are no longer optional; they are fundamental expectations in today's market."

Normalization matters because buyers rarely accept reported EBITDA at face value. As SVA Certified Public Accountants explains, private equity firms adjust earnings to reflect what they consider the real figure, including how owners pay themselves and how distributions are handled. Expect to provide:

• Three or more years of profit and loss statements and tax returns
• Owner compensation, perks, and distributions, separated from operating expenses
• One-time or non-recurring costs, documented with support
• Monthly revenue, not just annual totals, to reveal seasonality and trend

Which operational metrics do private equity groups scrutinize in diligence?

These operational numbers often decide whether a practice gets a strong multiple or a discounted one.

New patient trend by source

Buyers want to see new patient volume month over month for at least two to three years, broken out by source: referrals, insurance directories, search, paid advertising, and word of mouth. A rising total that depends on one channel is fragile. New patients spread across several channels suggest demand that does not depend on any one of them.

Patient retention and reactivation

How many patients return within their expected recall window? How many have lapsed? Retention shows whether revenue depends on constantly replacing patients or on a loyal base. Be ready to show active patient counts, recall compliance, and attrition over time.

Provider concentration

If the selling owner produces a large share of revenue, the buyer is purchasing a practice whose value may walk out the door. Expect requests for production and collections by provider, along with patient panel sizes. Buyers often require post-sale commitments and rollover equity from high-producing owners to offset that risk.

Payer mix

Buyers will break revenue down by commercial insurance, government programs, and self-pay, and they will examine reimbursement rates by payer. Heavy reliance on a single payer or low-reimbursing contracts raises questions about margin stability.

Per-location performance

For multi-site groups, consolidated numbers can hide a weak location dragging down a strong one. Buyers want revenue, visits, new patients, staffing costs, and margin for each site individually. If you cannot separate them cleanly, the buyer will assume the worst about the underperformer.

Why does a practice that can't produce these numbers get a weaker offer?

When a buyer asks for new patients by source and receives three versions from three systems, each disagreeing with the others, they lower the price instead of averaging the figures.

Slow, inconsistent answers create three specific problems:

• Higher perceived risk. Buyers assume a practice that does not track a number cannot manage it, and that risk lowers the multiple.
• More aggressive normalization. Without supporting data, buyers make conservative assumptions in their own favor.
• Weaker negotiating position. Deal terms tend to shift toward more earnouts and contingencies when the seller cannot prove growth claims.

Buyers also have strong incentives to look closely. They target well-performing practices with growth potential, as Triumphant Transition Partners notes, and growth is exactly what scattered data fails to prove.

When should you start tracking practice valuation metrics?

Two to three years before you plan to sell, at the latest. Flychain advises that owners begin preparing at least two to three years in advance. That window matters because buyers evaluate trends, and a trend requires history. You cannot backfill three years of clean, source-attributed new patient data in the month before a letter of intent.

Starting early also lets you fix what the data reveals. If provider concentration is high, you have time to grow associate production. If one location lags, you have time to turn it around before it shows up in a buyer's model.

How can you get diligence-ready now?

These steps strengthen your position whether a sale is two years or ten years away:

1. Define each metric once. Agree on exactly how you count a new patient, an active patient, and a retained patient, then apply it everywhere.
2. Consolidate your sources. Pull practice management, scheduling, billing, and marketing data into one consistent view instead of reconciling exports by hand.
3. Review monthly, by location and provider. Look at the same numbers a buyer will, so diligence holds no surprises.
4. Document adjustments as they happen. Record one-time expenses and owner-related costs throughout the year to support normalization later.
5. Run a mock diligence request. Ask your team to produce every metric above within 48 hours. The metrics they cannot produce show where to invest.

Check whether you could answer a buyer today

TruVue gives practice owners and executives one source for the operational numbers buyers scrutinize: new patient trends by source, retention, provider production, payer mix, and per-location performance. Schedule a TruVue demo and find out whether you could answer a buyer's diligence request today.

Frequently Asked Questions

What practice valuation metrics do buyers look at first?

Buyers start with normalized EBITDA, supported by several years of financial statements and tax returns. They then examine operational practice valuation metrics, including new patient trends by source, patient retention, provider concentration, payer mix, and per-location performance. These operational numbers show whether current earnings are likely to continue after ownership changes, which directly shapes the multiple offered.

Why do private equity groups normalize EBITDA when reviewing practice valuation metrics?

Private equity groups normalize EBITDA to estimate the practice's true ongoing earnings under new ownership. They adjust for owner compensation, personal expenses, distributions, and one-time costs. Because valuation multiples are applied to this adjusted figure, well-documented practice valuation metrics and clear supporting records help sellers avoid overly conservative adjustments that reduce the final offer.

How far in advance should I start tracking practice valuation metrics before selling?

Start tracking practice valuation metrics at least two to three years before a planned sale. Earlier is better. Buyers evaluate trends, not snapshots, so they need consistent historical data. Early tracking also gives you time to correct weaknesses such as high provider concentration or an underperforming location before buyers see them.

How does provider concentration affect practice valuation metrics and offers?

Provider concentration measures how much revenue depends on one or a few providers, usually the selling owner. High concentration is a core risk among practice valuation metrics because that revenue may leave with the provider. Buyers often respond with lower multiples, longer required post-sale commitments, rollover equity, or earnout structures tied to future performance.

Who helps practices organize practice valuation metrics before a sale?

TruVue, a healthcare practice operations intelligence platform (not an EMR), helps independent practices and multi-location groups consolidate practice valuation metrics into one consistent view. Owners use it to track new patients by source, retention, provider production, payer mix, and location performance, alongside advisors such as accountants and transition consultants who handle financial normalization and deal structure.